BioSpace News Archive

The last year has been a busy one for Bedford, Mass.-based Homology Medicines. Albert Seymour, Homology’s chief science officer, took time out to talk to BioSpace about the company and where it’s headed.

TLC announced that the company’s management team will be presenting at the following conferences

Event for St. Jude Children’s Research Hospital® unites American supporters of Arab descent

Suicide is the tenth leading cause of death in the United States and the 11th leading cause of death in Alabama.

Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) (“Liht” or the “Company”), a Nevada licensed cannabis cultivator and producer is pleased to announce that on April 18, 2019, it has entered into a Share Exchange Agreement (the “Agreement”) with Buds For You Inc. (“Buds For You”) – a late-stage cannabis cultivation, processing, and sales license applicant under the Cannabis Act – to acquire all issued and outstanding shares of Buds for You.

Meat, fish and eggs can be an important part of a healthy and environmentally responsible diet, say consumers in new global research from Cargill.

Community Servings, a nonprofit provider of medically tailored meals and nutrition services to individuals and families living with critical and chronic illnesses, announced today the publication of a study in the peer-reviewed journal JAMA Internal Medicine that provides strong new evidence linking medically tailored meal interventions to improved health outcomes and lower medical costs for high-need, high-cost patients.

The FDA is a public health agency that always strives to use the best available scientific evidence to promote and protect the well being of individuals.

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on Genitourinary Cancers Wednesday, April 24, from 5 to 9 p.m. at the Sheraton Needham Hotel in Needham, Massachusetts.

A new study in the Journal of Occupational and Environmental Medicine finds that concurrent treatment of chronic pain, depression, and/or anxiety and occupational injuries is associated with large increases in total workers’ compensation claim cost and delayed return to work.